Status:
RECRUITING
Addictive Threshold of Nicotine
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Addiction
Eligibility:
All Genders
21-59 years
Phase:
EARLY_PHASE1
Brief Summary
To determine the nicotine threshold dose(s) for discrimination, subjective-rewarding effects, -and reinforcement in smokers with different levels of dependence.
Detailed Description
The purpose of this project is to determine the nicotine threshold dose(s) for discrimination, subjective-rewarding effects, and reinforcement in smokers with different levels of dependence. Participa...
Eligibility Criteria
Inclusion
- to contact their primary care provider when necessary.
- Adults, aged 21 to 59 years. Individuals less than 21 will be excluded because the minimum age for purchasing tobacco products is 21 in our state. The upper age is set at 59 because there are no previous IV nicotine studies that enrolled smokers over the age of 59.
- Smoking at least for one year and more frequently than once a week, smoking status confirmed with a semi-quantitative urine nicotine test. Smokers will be stratified based on the level of dependence, assessed with the FTND scores (Heatherton et al. 1991) (low or no dependence 4 and moderate or high level of dependence 5.
- In good health as verified by medical history, screening examination, and screening laboratory tests.
- For women, report using acceptable birth control methods.
Exclusion
- History of major medical or psychiatric disorders that the physician investigator deems as contraindicated for the participant to be in the study
- regular current use of certain psychotropic medications (such as mood stabilizers, antipsychotics, or anxiolytics being prescribed to treat bipolar disorder, psychosis or anxiety spectrum disorders, respectively)
- current untreated alcohol or substance use disorder for any other recreational or prescription drugs other than nicotine
- for women, pregnant as determined by pregnancy screening, or breastfeeding
- seeking (or undergoing) treatment for tobacco dependence or smoking.
Key Trial Info
Start Date :
February 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2027
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06096714
Start Date
February 27 2024
End Date
January 30 2027
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Healthcare System
West Haven, Connecticut, United States, 06516